We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension

This study is currently recruiting participants.
Verified October 2016 by Yunfei Yuan, Sun Yat-sen University
Sponsor:
ClinicalTrials.gov Identifier:
NCT01642446
First Posted: July 17, 2012
Last Update Posted: October 17, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Yunfei Yuan, Sun Yat-sen University
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2022
  Estimated Primary Completion Date: June 2022 (Final data collection date for primary outcome measure)